Submit Deal

Eric Lev

Partner at AMPERSAND CAPITAL PARTNERS

Investor

Deal Bio

Total Deals6

Valued Deals1

Total Value£184M

Avg. Deal Size£184M

Market Context

Expertise (6)

Key Relationships

Sort

United States

Pharmaceuticals

Private EquityAcquisitionMajorityMergerPrivate

target

Peptides International

bidder

Ampersand Capital Partners

value n/a

4 dealmakers

United States

Biotechnology

AcquisitionMajorityDomesticPrivatePrivate Equity

target

Nexcelom Bioscience

bidder

Perkinelmer

£183m

7 dealmakers

Canada

Pharmaceuticals

MajorityPrivatePrivate EquityCross BorderAcquisition

target

NEXELIS

bidder

Iqvia

value n/a

28 dealmakers

United Kingdom

Pharmaceuticals

Cross BorderMajorityPrivateAcquisitionPrivate Equity

target

Lgc (drug Development Solutions Business)

bidder

Alliance Pharma Lc

value n/a

27 dealmakers

Czechia

Medical Equipment

AcquisitionCross BorderMergerPrivate EquityPrivate

target

GENEPROOF

bidder

American Laboratory Products Company

value n/a

13 dealmakers

United States

Biotechnology

DomesticPrivate EquityMajorityPrivateAcquisition

target

Biologos

bidder

Ampersand Capital Partners

value n/a

4 dealmakers

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.